|Stereotaxis Inc -- USA Stock|| |
USD 0.74 0.031 4.37%
CFO and Principal Accounting Officer
Mr. Martin C. Stammer is Chief Financial Officer of Stereotaxis, Inc., since February 2013. He previously served as Vice President, Controller since August 2012 and as Corporationrationrate Controller from July 2011 to August 2012. He joined the Company as Senior Manager, Financial Reporting in October 2009. Prior to joining the Company, from 2003 to 2009, Mr. Stammer was employed in various roles and capacities at Deloitte Touche LLP, including most recently as Audit Manager
Age: 35 CFO Since 2014
Stammer received his M.S. and B.S. in Accountancy from the University of Illinois and is a Certified Public Accountant.
Martin Stammer Latest Insider Activity
The company has return on total asset (ROA)
of (23.39) %
which means that it has lost $23.39 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (52.1) %
meaning that it created substantial loss on money invested by shareholders.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Stereotaxis operates under Medical Appliances Equipment classification in USA and traded on OTC Market exchange.Stereotaxis Inc (STXS) is traded on OTC Market in USA. It is located in MISSOURI, U.S.A and employs 120 people. Stereotaxis is listed under Medical Equipment category by Fama And French industry classification.